bibliographic entry 3814418 [be/3814418]
https://w3id.org/oc/corpus/be/3814418

is a

• bibliographic reference

content

• Sandhu SK, Schelman WR, Wilding G et al: The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial. Lancet Oncol 2013; 14: 882–892. PMID: 23810788

references

• https://w3id.org/oc/corpus/br/3006505